Gina Massa Mias
Compliance Officer at ESBATech, a Novartis Co. GmbH
Gina Massa Mias active positions
| Companies | Position | Start | End |
|---|---|---|---|
ESBATech, a Novartis Co. GmbH
 ESBATech, a Novartis Co. GmbH Miscellaneous Commercial ServicesCommercial Services ESBATech AG develops antibody fragment therapeutics. The firm's antibody fragment is derived from human antibody fragment scaffolds. It develops Immuna, an antigen-independent platform to screen, select, and optimize highly-stable and soluble, single-chain antibody fragments. The company was founded by Dominik Escher in September 1998 and is headquartered Schlieren, Switzerland. | Compliance Officer | - | - |
| Corporate Officer/Principal | - | - |
Career history of Gina Massa Mias
Former positions of Gina Massa Mias
| Companies | Position | Start | End |
|---|---|---|---|
| NOVARTIS AG | Corporate Officer/Principal | 31/12/2004 | - |
Training of Gina Massa Mias
| University of Massachusetts | Masters Business Admin |
Statistics
International
| Switzerland | 3 |
| United States | 2 |
Operational
| Corporate Officer/Principal | 2 |
| Compliance Officer | 1 |
| Masters Business Admin | 1 |
Sectoral
| Commercial Services | 2 |
| Consumer Services | 2 |
| Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| NOVARTIS AG | Health Technology |
| Private companies | 1 |
|---|---|
ESBATech, a Novartis Co. GmbH
ESBATech, a Novartis Co. GmbH Miscellaneous Commercial ServicesCommercial Services ESBATech AG develops antibody fragment therapeutics. The firm's antibody fragment is derived from human antibody fragment scaffolds. It develops Immuna, an antigen-independent platform to screen, select, and optimize highly-stable and soluble, single-chain antibody fragments. The company was founded by Dominik Escher in September 1998 and is headquartered Schlieren, Switzerland. | Commercial Services |
- Stock Market
- Insiders
- Gina Massa Mias
- Experience